How is CIN1 treated?
Sep 21, 2021
Source: Cainiu Health
Dr. Yan Ying
Introduction
CIN1 refers to low-grade cervical intraepithelial neoplasia, a precancerous condition that typically does not require specific treatment, as the body’s immune system can often cause the abnormal tissue to revert to normal. However, if an infection is present, antiviral therapy may be administered, usually in cycles lasting three months.
In recent years, the incidence of cervical cancer has been relatively high. CIN1 (Cervical Intraepithelial Neoplasia Grade 1) indicates a mild precancerous change in the cervical epithelium. This condition may spontaneously regress to normal tissue, but it also carries a risk of progression. Therefore, close follow-up and regular re-examinations are essential at this stage to prevent disease progression. So, how is CIN1 treated? Below, we address this question.
How is CIN1 Treated?
CIN1 refers to low-grade cervical intraepithelial neoplasia—a precancerous lesion that typically does not require immediate or specific treatment. In many cases, the body’s immune system can clear the abnormal cells and restore normal cervical epithelium. However, if a human papillomavirus (HPV) infection is present, antiviral therapy may be recommended—usually administered over a three-month course. After completing treatment, patients should undergo follow-up testing to determine whether HPV remains positive. If the lesion progresses or persists for two years during surveillance, intervention becomes necessary. The specific treatment approach must be determined by a physician based on individual clinical assessment.
Knowledge Expansion: What Are the Symptoms of Cervical Cancer?
1. Menstrual Irregularities
Menstruation is a unique physiological process in women, and menstrual irregularities often serve as an important early warning sign. Such disturbances are frequently the first manifestation of various underlying conditions. In cervical cancer, patients may experience abnormal uterine bleeding—including amenorrhea (absence of menstruation)—and passage of dark clots during menses.
2. Vaginal Bleeding
Sexual intercourse is a direct means of fostering intimacy between partners. Women with cervical lesions or early-stage cervical cancer may experience postcoital vaginal bleeding—a symptom often accompanied by lower abdominal distension or discomfort. Under normal circumstances, sexual intercourse does not cause vaginal bleeding; thus, its occurrence warrants medical evaluation, especially when associated with suspected cervical pathology.
The above outlines the management of CIN1. We hope this information is helpful to you.
